Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-04-16

Clinical Trial Update: Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Zotepine and Risperidone in aggressive schizophrenia patients in an acute ward was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)
  • Zotepine (Zotepine)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED